-
Alternative name
BH, bleomycin hydrolase, BLM hydrolase, BLMH, BMH antibody
-
Catalog
A000907
-
Size100μg
-
Formliquid
-
Purity≥95% as determined by SDS-PAGE
-
StoragePBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20℃ for 24 months (Avoid repeated freeze / thaw cycles.)
-
ClonalityPolyclonal Antibody
-
Host Rabbit
-
Species ReactivityHuman,Mouse ,Rat
-
Applications Tested/SuitableELISA,WB,IHC,IF
-
PurificationImmunogen affinity purified
-
Immunogenbleomycin hydrolase
-
IHCImmunohistochemistry of paraffin-embedded human colon cancer using A000907(BLMH antibody) at dilution of 1:100
-
Western Blothuman colon tissue were subjected to SDS PAGE followed by western blot with A000907(BLMH antibody) at dilution of 1:600
-
Recommended dilutionWB : 1:500-1:5000
-
Product Description specificalThe normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B- aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity.
-
Gene nameBLMH
-
Uniprot IDQ13867
-
Observed M.W.50 kDa
-